The two struck a deal Monday for Hims to offer official versions of Novo Nordisk’s GLP-1 drugs Ozempic and Wegovy.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Novo and Hims’ April team-up turned the two firms from competitors into collaborators at just the right moment.